Article Versions Notes

Cho H, Shim MK, Yang S, Song S, Moon Y, Kim J, Byun Y, Ahn C-H, Kim K. Cathepsin B-Overexpressed Tumor Cell Activatable Albumin-Binding Doxorubicin Prodrug for Cancer-Targeted Therapy. Pharmaceutics. 2022; 14(1):83. https://doi.org/10.3390/pharmaceutics14010083

Cho, Hanhee, Man Kyu Shim, Suah Yang, Sukyung Song, Yujeong Moon, Jinseong Kim, Youngro Byun, Cheol-Hee Ahn, and Kwangmeyung Kim. 2022. "Cathepsin B-Overexpressed Tumor Cell Activatable Albumin-Binding Doxorubicin Prodrug for Cancer-Targeted Therapy" Pharmaceutics 14, no. 1: 83. https://doi.org/10.3390/pharmaceutics14010083

Cho, H., Shim, M. K., Yang, S., Song, S., Moon, Y., Kim, J., Byun, Y., Ahn, C.-H., & Kim, K. (2022). Cathepsin B-Overexpressed Tumor Cell Activatable Albumin-Binding Doxorubicin Prodrug for Cancer-Targeted Therapy. Pharmaceutics, 14(1), 83. https://doi.org/10.3390/pharmaceutics14010083